ReviewActa Cardiologica Sinica2025
The Efficacy of Aromatherapy in Alleviating Anxiety among Acute Myocardial Infarction Patients: A Systematic Review and Meta-Analysis.
Review in Acta Cardiologica Sinica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Effects of aromatherapy on objective physiological outcomes in adult ICU patients: a systematic review.Frontiers in medicine · 2026Pooled it
- Effect of aromatherapy with Matricaria chamomilla in pain and anxiety management in hospital settings: A scoping review protocol.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The primary aim of this study was to explore the effectiveness of aromatherapy in alleviating hospitalization-related anxiety in patients with acute myocardial infarction (AMI). Methods: A search of PubMed, Ovid Medline, Cochrane Library, CINAHL Database, Taiwan Periodical Literature Index System, and Airiti Library was conducted in October 2023. Following the inclusion and exclusion criteria, randomized controlled trials on aromatherapy in patients with AMI aged 18 years or older were identified. The risk of bias in the retrieved trials was assessed using the revised Cochrane Risk-of-Bias Tool for randomized controlled trials. Results: A total of 14 trials were identified. Aromatherapy was found to significantly reduce anxiety (Hedges's g = -2.087, 95% confidence interval [CI] = -2.8341 to -1.341, p < 0.001), although heterogeneity was notably high (I2 = 96.7%). The effects of different aromatherapies on anxiety were inconsistent. Geranium (Hedges's g = -6.970, 95% CI= -10.283 to -3.675, p < 0.001), M. Chamomile (Hedges's g = -3.735, 95% CI= -6.881 to -0.590, p = 0.002), and C. Aurantium (Hedges's g = -3.614, 95% CI= -5.885 to -1.343, p < 0.001) were found to significantly reduce anxiety. Aromatherapy was found to have a significant effect in lowering systolic blood pressure in these patients (Hedges's g = -0.903, 95% CI = -1.689 to -0.117, p = 0.024). Conclusions: Our findings suggest that clinical staff can apply aromatherapy in the care of AMI patients to alleviate anxiety and improve the quality of care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.